Passa al contenuto
Merck

The role of vitamin D in reducing cancer risk and progression.

Nature reviews. Cancer (2014-04-08)
David Feldman, Aruna V Krishnan, Srilatha Swami, Edward Giovannucci, Brian J Feldman
ABSTRACT

Vitamin D is not really a vitamin but the precursor to the potent steroid hormone calcitriol, which has widespread actions throughout the body. Calcitriol regulates numerous cellular pathways that could have a role in determining cancer risk and prognosis. Although epidemiological and early clinical trials are inconsistent, and randomized control trials in humans do not yet exist to conclusively support a beneficial role for vitamin D, accumulating results from preclinical and some clinical studies strongly suggest that vitamin D deficiency increases the risk of developing cancer and that avoiding deficiency and adding vitamin D supplements might be an economical and safe way to reduce cancer incidence and improve cancer prognosis and outcome.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Colecalciferolo, ≥98% (HPLC)
Sigma-Aldrich
1α,25-diidrossivitamina D3, ≥99% (HPLC)
Supelco
Colecalciferolo (D3), analytical standard
USP
Colecalciferolo, United States Pharmacopeia (USP) Reference Standard
Supelco
Vitamin D3 solution, 1 mg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
1α,25-Dihydroxyvitamin D3 solution, 5 μg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Colecalciferolo, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
1α,25-diidrossivitamina D3, ≥97.0% (HPLC)
Colecalciferolo, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Colecalciferolo, meets USP testing specifications
Sigma-Aldrich
Colecalciferolo, analytical standard
1α,25-diidrossivitamina D3, European Pharmacopoeia (EP) Reference Standard